Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Therapeutic prostate-specific antigen (PSA) –targeted poxviral vaccines for prostate cancer have been well tolerated. PROSTVAC-VF treatment was evaluated for safety and for prolongation of progression-free survival (PFS) and overall survival (OS) in a randomized, controlled, and blinded pha...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kantoff, Philip W., Schuetz, Thomas J., Blumenstein, Brent A., Glode, L. Michael, Bilhartz, David L., Wyand, Michael, Manson, Kelledy, Panicali, Dennis L., Laus, Reiner, Schlom, Jeffrey, Dahut, William L., Arlen, Philip M., Gulley, James L., Godfrey, Wayne R.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2010
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2834462/
https://ncbi.nlm.nih.gov/pubmed/20100959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.0597
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki